Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, T-Cell, Cutaneous | 19 | 2022 | 209 | 4.180 |
Why?
|
Skin | 41 | 2023 | 4468 | 2.970 |
Why?
|
Mycosis Fungoides | 10 | 2023 | 167 | 2.440 |
Why?
|
T-Lymphocytes | 29 | 2024 | 10183 | 2.380 |
Why?
|
T-Lymphocyte Subsets | 15 | 2022 | 1811 | 2.120 |
Why?
|
Skin Neoplasms | 28 | 2024 | 5797 | 2.080 |
Why?
|
Immunologic Memory | 15 | 2022 | 1354 | 1.930 |
Why?
|
Psoriasis | 9 | 2023 | 939 | 1.420 |
Why?
|
CD8-Positive T-Lymphocytes | 17 | 2023 | 4554 | 1.400 |
Why?
|
T-Lymphocytes, Helper-Inducer | 4 | 2018 | 975 | 1.150 |
Why?
|
Skin Diseases | 8 | 2023 | 1089 | 1.010 |
Why?
|
Th17 Cells | 4 | 2017 | 789 | 0.820 |
Why?
|
E-Selectin | 6 | 2013 | 576 | 0.810 |
Why?
|
Facial Transplantation | 2 | 2023 | 221 | 0.800 |
Why?
|
Interleukin-9 | 3 | 2016 | 58 | 0.760 |
Why?
|
Interleukin-13 | 2 | 2013 | 371 | 0.740 |
Why?
|
Receptors, Antigen, T-Cell | 9 | 2023 | 2536 | 0.720 |
Why?
|
Dentate Gyrus | 1 | 2021 | 163 | 0.680 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2023 | 3076 | 0.670 |
Why?
|
Dermatitis, Atopic | 6 | 2023 | 710 | 0.660 |
Why?
|
Interleukins | 4 | 2013 | 782 | 0.640 |
Why?
|
Drive | 1 | 2018 | 34 | 0.620 |
Why?
|
Antigens, CD1 | 5 | 2023 | 439 | 0.610 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2018 | 57 | 0.600 |
Why?
|
Monitoring, Immunologic | 1 | 2018 | 98 | 0.590 |
Why?
|
Interleukin-17 | 7 | 2020 | 908 | 0.590 |
Why?
|
Immunoglobulin E | 1 | 2024 | 1493 | 0.590 |
Why?
|
Sezary Syndrome | 3 | 2021 | 77 | 0.580 |
Why?
|
Arthritis | 1 | 2022 | 666 | 0.570 |
Why?
|
Aminoquinolines | 3 | 2016 | 108 | 0.540 |
Why?
|
Antigen Presentation | 2 | 2021 | 1254 | 0.540 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 8 | 2015 | 900 | 0.490 |
Why?
|
Interferon-gamma | 5 | 2021 | 3160 | 0.480 |
Why?
|
Inflammation | 6 | 2024 | 10757 | 0.460 |
Why?
|
Autoantibodies | 1 | 2022 | 2119 | 0.450 |
Why?
|
Th1 Cells | 3 | 2013 | 1033 | 0.450 |
Why?
|
Autocrine Communication | 1 | 2014 | 169 | 0.430 |
Why?
|
Interleukin-4 | 2 | 2015 | 1133 | 0.430 |
Why?
|
Interleukin-15 | 3 | 2013 | 183 | 0.420 |
Why?
|
Erythema | 1 | 2014 | 262 | 0.420 |
Why?
|
Radiotherapy | 1 | 2019 | 1505 | 0.420 |
Why?
|
Lymphocyte Activation | 10 | 2021 | 5498 | 0.410 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2013 | 4024 | 0.410 |
Why?
|
Paracrine Communication | 1 | 2014 | 278 | 0.400 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2013 | 321 | 0.390 |
Why?
|
Health | 1 | 2015 | 395 | 0.390 |
Why?
|
Th2 Cells | 3 | 2013 | 1048 | 0.380 |
Why?
|
Interleukin-2 | 5 | 2023 | 1890 | 0.380 |
Why?
|
Lipids | 2 | 2023 | 3336 | 0.370 |
Why?
|
Leukemia | 2 | 2016 | 1522 | 0.340 |
Why?
|
Cell Nucleus | 1 | 2018 | 2909 | 0.330 |
Why?
|
Antineoplastic Agents | 7 | 2016 | 13629 | 0.330 |
Why?
|
Disease | 1 | 2015 | 671 | 0.330 |
Why?
|
Imidazoles | 1 | 2015 | 1178 | 0.330 |
Why?
|
Humans | 95 | 2024 | 760261 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3451 | 0.320 |
Why?
|
Dermatitis | 3 | 2019 | 200 | 0.320 |
Why?
|
Graft Rejection | 2 | 2023 | 4423 | 0.320 |
Why?
|
Cell Separation | 5 | 2010 | 1720 | 0.310 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2022 | 3618 | 0.310 |
Why?
|
Immunity, Innate | 5 | 2023 | 3046 | 0.310 |
Why?
|
Dermatitis, Contact | 2 | 2023 | 133 | 0.300 |
Why?
|
Myeloid Cells | 1 | 2012 | 821 | 0.290 |
Why?
|
Lymphocytes | 3 | 2023 | 2612 | 0.280 |
Why?
|
Immune System | 4 | 2018 | 795 | 0.280 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9388 | 0.280 |
Why?
|
Antigens, CD | 7 | 2015 | 4002 | 0.270 |
Why?
|
Antigens, Neoplasm | 7 | 2016 | 1999 | 0.270 |
Why?
|
Cells, Cultured | 14 | 2020 | 18968 | 0.270 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2017 | 801 | 0.270 |
Why?
|
Cell Movement | 9 | 2017 | 5206 | 0.260 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 2019 | 345 | 0.260 |
Why?
|
Tumor Escape | 1 | 2008 | 371 | 0.250 |
Why?
|
Forkhead Transcription Factors | 6 | 2013 | 1613 | 0.250 |
Why?
|
Membrane Glycoproteins | 6 | 2013 | 3731 | 0.250 |
Why?
|
Mice, Inbred NOD | 5 | 2020 | 1837 | 0.250 |
Why?
|
Lung | 2 | 2022 | 9989 | 0.250 |
Why?
|
Genes, T-Cell Receptor beta | 2 | 2018 | 71 | 0.250 |
Why?
|
Mice | 23 | 2022 | 81216 | 0.240 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2012 | 1765 | 0.240 |
Why?
|
Lectins, C-Type | 3 | 2015 | 591 | 0.230 |
Why?
|
Transcription Factors | 4 | 2018 | 12100 | 0.230 |
Why?
|
Keratinocytes | 2 | 2021 | 792 | 0.230 |
Why?
|
Superantigens | 1 | 2023 | 127 | 0.220 |
Why?
|
Receptors, Lymphocyte Homing | 2 | 2018 | 142 | 0.220 |
Why?
|
Animals | 28 | 2023 | 167940 | 0.220 |
Why?
|
Nitric Oxide | 1 | 2012 | 2141 | 0.220 |
Why?
|
Receptors, Bombesin | 1 | 2022 | 26 | 0.210 |
Why?
|
Staphylococcal Skin Infections | 1 | 2023 | 78 | 0.210 |
Why?
|
Mice, SCID | 4 | 2020 | 2627 | 0.210 |
Why?
|
Candida albicans | 2 | 2017 | 378 | 0.210 |
Why?
|
PUVA Therapy | 2 | 2021 | 101 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9274 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6855 | 0.200 |
Why?
|
Transforming Growth Factor beta | 4 | 2014 | 1956 | 0.200 |
Why?
|
Nevus | 1 | 2024 | 205 | 0.200 |
Why?
|
Chemokines | 2 | 2022 | 962 | 0.200 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2018 | 4355 | 0.200 |
Why?
|
Lymphoma, T-Cell | 2 | 2022 | 305 | 0.200 |
Why?
|
Lymphocyte Count | 2 | 2022 | 780 | 0.190 |
Why?
|
Anthralin | 1 | 2021 | 5 | 0.190 |
Why?
|
Mucin-1 | 2 | 2017 | 539 | 0.190 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2023 | 219 | 0.190 |
Why?
|
Melanoma | 5 | 2024 | 5695 | 0.190 |
Why?
|
Neurons | 1 | 2021 | 9416 | 0.190 |
Why?
|
Graft vs Host Disease | 3 | 2022 | 3023 | 0.190 |
Why?
|
Antibody Formation | 1 | 2005 | 1400 | 0.180 |
Why?
|
Photopheresis | 1 | 2021 | 35 | 0.180 |
Why?
|
Fibroblasts | 3 | 2006 | 4091 | 0.180 |
Why?
|
Plasma Cells | 1 | 2024 | 592 | 0.180 |
Why?
|
Human papillomavirus 16 | 2 | 2014 | 266 | 0.180 |
Why?
|
Galectin 1 | 2 | 2012 | 128 | 0.180 |
Why?
|
Phototherapy | 1 | 2023 | 367 | 0.180 |
Why?
|
Cell Proliferation | 6 | 2021 | 10434 | 0.180 |
Why?
|
Hemolysin Proteins | 1 | 2020 | 114 | 0.170 |
Why?
|
Cytokines | 7 | 2021 | 7345 | 0.170 |
Why?
|
Membrane Lipids | 1 | 2021 | 251 | 0.170 |
Why?
|
Immunity, Cellular | 1 | 2005 | 1558 | 0.170 |
Why?
|
Cell Differentiation | 4 | 2018 | 11480 | 0.170 |
Why?
|
Electrons | 1 | 2021 | 264 | 0.170 |
Why?
|
Flow Cytometry | 7 | 2018 | 5873 | 0.170 |
Why?
|
Palatine Tonsil | 2 | 1997 | 193 | 0.160 |
Why?
|
Cancer Vaccines | 3 | 2016 | 1044 | 0.160 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2012 | 514 | 0.160 |
Why?
|
Chemokine CXCL12 | 1 | 2021 | 454 | 0.160 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 305 | 0.160 |
Why?
|
Synovial Membrane | 1 | 2021 | 524 | 0.160 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2014 | 387 | 0.160 |
Why?
|
Alopecia Areata | 1 | 2021 | 127 | 0.160 |
Why?
|
Interleukin-10 | 3 | 2009 | 1174 | 0.150 |
Why?
|
Foreskin | 1 | 2018 | 31 | 0.150 |
Why?
|
Receptors, CCR4 | 3 | 2006 | 77 | 0.150 |
Why?
|
Administration, Topical | 3 | 2016 | 697 | 0.150 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 311 | 0.150 |
Why?
|
Proteomics | 4 | 2024 | 3810 | 0.140 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 11902 | 0.140 |
Why?
|
Tenascin | 1 | 1997 | 62 | 0.140 |
Why?
|
Immunophenotyping | 3 | 2018 | 1870 | 0.140 |
Why?
|
Skin Transplantation | 1 | 2022 | 1083 | 0.140 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 2204 | 0.130 |
Why?
|
Proteome | 3 | 2024 | 1856 | 0.130 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2011 | 584 | 0.130 |
Why?
|
Coculture Techniques | 2 | 2013 | 1340 | 0.130 |
Why?
|
Feces | 1 | 2022 | 1466 | 0.130 |
Why?
|
Receptors, CXCR4 | 1 | 2021 | 728 | 0.130 |
Why?
|
Self Tolerance | 2 | 2007 | 124 | 0.130 |
Why?
|
Antigen-Presenting Cells | 2 | 2020 | 967 | 0.130 |
Why?
|
Azacitidine | 1 | 2017 | 334 | 0.130 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2018 | 352 | 0.130 |
Why?
|
Tissue Banks | 1 | 2016 | 185 | 0.120 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 393 | 0.120 |
Why?
|
Adaptive Immunity | 2 | 2017 | 724 | 0.120 |
Why?
|
Interleukin-1beta | 1 | 2021 | 999 | 0.120 |
Why?
|
Candidiasis | 1 | 2017 | 364 | 0.120 |
Why?
|
Receptors, IgG | 1 | 2018 | 565 | 0.120 |
Why?
|
Receptors, Chemokine | 3 | 2006 | 654 | 0.120 |
Why?
|
Integrin alpha Chains | 1 | 2015 | 95 | 0.120 |
Why?
|
Kinetics | 1 | 2022 | 6378 | 0.120 |
Why?
|
Langerhans Cells | 2 | 2012 | 171 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1252 | 0.120 |
Why?
|
Bacterial Toxins | 1 | 2020 | 931 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2022 | 2978 | 0.120 |
Why?
|
Scleroderma, Systemic | 1 | 2018 | 344 | 0.120 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4739 | 0.110 |
Why?
|
Congresses as Topic | 1 | 2019 | 804 | 0.110 |
Why?
|
Cytoplasm | 1 | 2018 | 1518 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2017 | 3584 | 0.110 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2015 | 111 | 0.110 |
Why?
|
Interleukin-23 | 1 | 2015 | 198 | 0.110 |
Why?
|
Mast Cells | 2 | 2018 | 1428 | 0.110 |
Why?
|
Immunotherapy | 2 | 2021 | 4637 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5644 | 0.110 |
Why?
|
Aged | 14 | 2024 | 168995 | 0.110 |
Why?
|
Hyaluronic Acid | 1 | 1996 | 482 | 0.110 |
Why?
|
Nitroarginine | 1 | 2012 | 66 | 0.100 |
Why?
|
Phenotype | 6 | 2016 | 16543 | 0.100 |
Why?
|
Allergens | 2 | 2018 | 1399 | 0.100 |
Why?
|
Tumor Cells, Cultured | 3 | 2015 | 6131 | 0.100 |
Why?
|
Dendritic Cells | 3 | 2009 | 2730 | 0.100 |
Why?
|
Arginase | 1 | 2012 | 80 | 0.100 |
Why?
|
Leukemia, T-Cell | 1 | 2012 | 101 | 0.100 |
Why?
|
Autoimmunity | 2 | 2010 | 1370 | 0.100 |
Why?
|
Bacteria | 1 | 2022 | 2196 | 0.100 |
Why?
|
Glycoproteins | 2 | 2012 | 2208 | 0.100 |
Why?
|
Toll-Like Receptor 7 | 2 | 2016 | 177 | 0.100 |
Why?
|
Infant, Newborn | 3 | 2022 | 26168 | 0.100 |
Why?
|
Macrophages | 1 | 2006 | 5745 | 0.100 |
Why?
|
Receptors, CCR2 | 1 | 2012 | 215 | 0.090 |
Why?
|
Antigens | 3 | 2012 | 1447 | 0.090 |
Why?
|
Lymphotoxin-alpha | 1 | 2011 | 94 | 0.090 |
Why?
|
Dermis | 1 | 2012 | 202 | 0.090 |
Why?
|
Cell Adhesion Molecules | 1 | 1997 | 1602 | 0.090 |
Why?
|
Male | 19 | 2024 | 359413 | 0.090 |
Why?
|
Lymph Nodes | 3 | 2018 | 3491 | 0.090 |
Why?
|
Nevus, Halo | 1 | 2010 | 5 | 0.090 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 13456 | 0.090 |
Why?
|
Gene Expression | 1 | 2023 | 7592 | 0.090 |
Why?
|
HLA-DR Antigens | 1 | 2012 | 630 | 0.090 |
Why?
|
Immunity, Mucosal | 1 | 2014 | 481 | 0.090 |
Why?
|
Cell Division | 2 | 2009 | 4462 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2021 | 58947 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3448 | 0.090 |
Why?
|
Tumor Burden | 2 | 2013 | 1897 | 0.090 |
Why?
|
L-Selectin | 2 | 2010 | 209 | 0.090 |
Why?
|
Female | 24 | 2024 | 391011 | 0.090 |
Why?
|
Apoptosis | 4 | 2017 | 9497 | 0.090 |
Why?
|
Interferons | 1 | 2013 | 705 | 0.090 |
Why?
|
Receptors, CCR6 | 2 | 2006 | 73 | 0.080 |
Why?
|
Prospective Studies | 5 | 2021 | 54263 | 0.080 |
Why?
|
Middle Aged | 14 | 2024 | 220175 | 0.080 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2016 | 1090 | 0.080 |
Why?
|
Cell Polarity | 1 | 2012 | 638 | 0.080 |
Why?
|
Signal Transduction | 5 | 2024 | 23363 | 0.080 |
Why?
|
K562 Cells | 2 | 2021 | 640 | 0.080 |
Why?
|
Epidermis | 1 | 2012 | 529 | 0.080 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2009 | 133 | 0.080 |
Why?
|
Immune Tolerance | 2 | 2009 | 2299 | 0.080 |
Why?
|
Vitiligo | 1 | 2010 | 98 | 0.080 |
Why?
|
Perforin | 1 | 2009 | 167 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2017 | 3107 | 0.080 |
Why?
|
Models, Immunological | 2 | 2012 | 513 | 0.080 |
Why?
|
Skin Physiological Phenomena | 1 | 2009 | 189 | 0.080 |
Why?
|
Viral Vaccines | 1 | 2014 | 598 | 0.080 |
Why?
|
Gene Silencing | 1 | 2015 | 1511 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1902 | 0.080 |
Why?
|
Vulvar Neoplasms | 1 | 2010 | 265 | 0.080 |
Why?
|
Granzymes | 1 | 2009 | 276 | 0.070 |
Why?
|
Endothelial Cells | 2 | 2012 | 3537 | 0.070 |
Why?
|
Ligands | 3 | 2010 | 3277 | 0.070 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 912 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2282 | 0.070 |
Why?
|
Neoplasm Proteins | 3 | 2017 | 3613 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2015 | 1135 | 0.070 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2006 | 40 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1899 | 0.070 |
Why?
|
Clone Cells | 2 | 2022 | 1663 | 0.070 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2006 | 91 | 0.070 |
Why?
|
Base Sequence | 1 | 2017 | 12447 | 0.070 |
Why?
|
Immunologic Surveillance | 1 | 2006 | 92 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3763 | 0.070 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 590 | 0.060 |
Why?
|
Clonal Deletion | 1 | 2005 | 74 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8498 | 0.060 |
Why?
|
Health Status | 1 | 2019 | 4081 | 0.060 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2006 | 198 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12806 | 0.060 |
Why?
|
Interleukin-7 | 1 | 2005 | 142 | 0.060 |
Why?
|
Hematoma | 1 | 1990 | 769 | 0.060 |
Why?
|
Endocytosis | 1 | 2009 | 960 | 0.060 |
Why?
|
Caspase 1 | 1 | 2006 | 226 | 0.060 |
Why?
|
Paired Box Transcription Factors | 1 | 2005 | 207 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2017 | 22041 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 64947 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2378 | 0.060 |
Why?
|
Dioctyl Sulfosuccinic Acid | 1 | 2004 | 8 | 0.060 |
Why?
|
Vaccinia | 2 | 2017 | 71 | 0.060 |
Why?
|
Adenosine Deaminase | 1 | 2006 | 251 | 0.060 |
Why?
|
Epitopes | 1 | 2011 | 2506 | 0.060 |
Why?
|
Herpes Labialis | 1 | 2004 | 28 | 0.060 |
Why?
|
Adult | 10 | 2024 | 219847 | 0.060 |
Why?
|
Interleukin-18 | 1 | 2006 | 251 | 0.060 |
Why?
|
Blood | 1 | 2006 | 586 | 0.060 |
Why?
|
Resorcinols | 1 | 2023 | 41 | 0.060 |
Why?
|
Immunoglobulin G | 2 | 2018 | 4546 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5120 | 0.060 |
Why?
|
Escherichia coli Proteins | 1 | 2010 | 1066 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4573 | 0.060 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2016 | 123 | 0.060 |
Why?
|
Antigens, Differentiation | 1 | 2006 | 912 | 0.060 |
Why?
|
Staphylococcus | 1 | 2023 | 156 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2006 | 553 | 0.050 |
Why?
|
Peptides | 1 | 2015 | 4358 | 0.050 |
Why?
|
Stilbenes | 1 | 2023 | 155 | 0.050 |
Why?
|
Vaccinia virus | 2 | 2017 | 332 | 0.050 |
Why?
|
Biopsy | 3 | 2010 | 6775 | 0.050 |
Why?
|
Receptors, CCR8 | 1 | 2022 | 28 | 0.050 |
Why?
|
Papillomavirus E7 Proteins | 2 | 2014 | 111 | 0.050 |
Why?
|
Enterotoxins | 1 | 2023 | 367 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8641 | 0.050 |
Why?
|
Cell Survival | 4 | 2017 | 5796 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4264 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3726 | 0.050 |
Why?
|
Autoantigens | 1 | 2005 | 877 | 0.050 |
Why?
|
Down-Regulation | 1 | 2008 | 2918 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2022 | 283 | 0.050 |
Why?
|
Oxidation-Reduction | 2 | 2017 | 2222 | 0.050 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2414 | 0.050 |
Why?
|
Receptors, Notch | 1 | 2005 | 742 | 0.050 |
Why?
|
Oncogene Proteins, Viral | 2 | 2014 | 341 | 0.050 |
Why?
|
Thymus Gland | 1 | 2005 | 1246 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11141 | 0.040 |
Why?
|
Cell Adhesion | 2 | 1997 | 3096 | 0.040 |
Why?
|
HLA Antigens | 1 | 2005 | 1369 | 0.040 |
Why?
|
Homeostasis | 2 | 2012 | 3305 | 0.040 |
Why?
|
Young Adult | 2 | 2019 | 58673 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11708 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 2 | 2020 | 1828 | 0.040 |
Why?
|
Stromal Cells | 2 | 2014 | 1327 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4357 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39254 | 0.040 |
Why?
|
Cell Communication | 1 | 2006 | 1642 | 0.040 |
Why?
|
Neutrophils | 1 | 2012 | 3770 | 0.040 |
Why?
|
Austria | 1 | 2019 | 206 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2010 | 1600 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2010 | 3665 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8487 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2008 | 3207 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2138 | 0.040 |
Why?
|
Internet | 2 | 2016 | 3074 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9196 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1381 | 0.040 |
Why?
|
Immunocompetence | 1 | 2017 | 137 | 0.040 |
Why?
|
Phospholipids | 1 | 2021 | 789 | 0.040 |
Why?
|
Immunologic Techniques | 1 | 1997 | 213 | 0.040 |
Why?
|
Dermatologic Agents | 1 | 2021 | 306 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8551 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2024 | 2192 | 0.030 |
Why?
|
Japan | 1 | 2021 | 1369 | 0.030 |
Why?
|
Cations, Divalent | 1 | 1996 | 168 | 0.030 |
Why?
|
Selectins | 1 | 1996 | 101 | 0.030 |
Why?
|
Hyaluronoglucosaminidase | 1 | 1996 | 135 | 0.030 |
Why?
|
Vaccines, Subunit | 1 | 2016 | 161 | 0.030 |
Why?
|
Rheology | 1 | 1997 | 348 | 0.030 |
Why?
|
Edetic Acid | 1 | 1996 | 281 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 80301 | 0.030 |
Why?
|
Vitamin D | 1 | 2009 | 3293 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5039 | 0.030 |
Why?
|
Poxviridae | 1 | 2015 | 37 | 0.030 |
Why?
|
Haptens | 1 | 2015 | 163 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2017 | 296 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2017 | 22025 | 0.030 |
Why?
|
Chelating Agents | 1 | 1996 | 384 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 353 | 0.030 |
Why?
|
NADP | 1 | 2015 | 223 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 223 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2897 | 0.030 |
Why?
|
Brain | 1 | 2021 | 26912 | 0.030 |
Why?
|
Protein Binding | 1 | 2006 | 9336 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 714 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 368 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 16905 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4814 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2016 | 10340 | 0.030 |
Why?
|
Organ Specificity | 1 | 2018 | 1955 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18134 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 414 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1005 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 2014 | 385 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2866 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9468 | 0.030 |
Why?
|
Pilot Projects | 2 | 2023 | 8553 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 2 | 2013 | 1442 | 0.030 |
Why?
|
Glutathione | 1 | 2015 | 582 | 0.030 |
Why?
|
Integrins | 1 | 1997 | 840 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2014 | 553 | 0.030 |
Why?
|
Radiation Chimera | 1 | 2012 | 216 | 0.030 |
Why?
|
Biological Transport | 1 | 2017 | 2087 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14396 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2014 | 446 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2014 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.030 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2012 | 107 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1996 | 1616 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6226 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1462 | 0.020 |
Why?
|
Cell Membrane | 1 | 2021 | 3683 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2012 | 144 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 384 | 0.020 |
Why?
|
Immunization, Secondary | 1 | 2014 | 366 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 87747 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 1996 | 1666 | 0.020 |
Why?
|
Receptors, Interleukin | 1 | 2012 | 243 | 0.020 |
Why?
|
Anaphylaxis | 1 | 2018 | 753 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1612 | 0.020 |
Why?
|
Vaccination | 2 | 2014 | 3360 | 0.020 |
Why?
|
Antigenic Variation | 1 | 2011 | 118 | 0.020 |
Why?
|
Chemokine CCL22 | 1 | 2010 | 27 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1228 | 0.020 |
Why?
|
Integrin alpha4 | 1 | 2010 | 87 | 0.020 |
Why?
|
Chemokine CCL21 | 1 | 2010 | 51 | 0.020 |
Why?
|
Integrin beta Chains | 1 | 2010 | 115 | 0.020 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2010 | 94 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2015 | 12762 | 0.020 |
Why?
|
Receptors, CCR7 | 1 | 2010 | 108 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2014 | 585 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2014 | 980 | 0.020 |
Why?
|
Pigmentation | 1 | 2010 | 144 | 0.020 |
Why?
|
P-Selectin | 1 | 2012 | 600 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4168 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 562 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2018 | 1159 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 1996 | 1726 | 0.020 |
Why?
|
Hematocrit | 1 | 1990 | 630 | 0.020 |
Why?
|
Tyrosine | 1 | 2013 | 1440 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 645 | 0.020 |
Why?
|
Binding Sites | 1 | 1997 | 6050 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 877 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2010 | 663 | 0.020 |
Why?
|
Fibrin | 1 | 1990 | 505 | 0.020 |
Why?
|
Chemotaxis | 1 | 2010 | 598 | 0.020 |
Why?
|
Blood Vessels | 1 | 2013 | 1112 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2525 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15626 | 0.020 |
Why?
|
Melanocytes | 1 | 2010 | 512 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9282 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9531 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2520 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1628 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 1 | 2006 | 562 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2874 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12156 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2805 | 0.010 |
Why?
|
Ointments | 1 | 2004 | 58 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2945 | 0.010 |
Why?
|
Hemoglobins | 1 | 1990 | 1521 | 0.010 |
Why?
|
Blood Coagulation | 1 | 1990 | 1156 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2012 | 3735 | 0.010 |
Why?
|
Self Medication | 1 | 2004 | 117 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2006 | 584 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1990 | 36247 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5782 | 0.010 |
Why?
|
Leukocytes | 1 | 2010 | 2030 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1347 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6067 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17628 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6543 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6181 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 41317 | 0.010 |
Why?
|
Acute Disease | 1 | 1990 | 7268 | 0.010 |
Why?
|
Oxygen | 1 | 1990 | 4189 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4437 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29636 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40133 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13505 | 0.010 |
Why?
|
Child | 1 | 2022 | 79758 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2004 | 12412 | 0.010 |
Why?
|